CN114028298A - Preparation method and application of pueraria extract nanosuspension for eye care - Google Patents
Preparation method and application of pueraria extract nanosuspension for eye care Download PDFInfo
- Publication number
- CN114028298A CN114028298A CN202111550426.0A CN202111550426A CN114028298A CN 114028298 A CN114028298 A CN 114028298A CN 202111550426 A CN202111550426 A CN 202111550426A CN 114028298 A CN114028298 A CN 114028298A
- Authority
- CN
- China
- Prior art keywords
- water
- extract
- suspension
- radix puerariae
- nanometer suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006070 nanosuspension Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000219780 Pueraria Species 0.000 title claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 34
- 241000219781 Pueraria montana var. lobata Species 0.000 claims abstract description 30
- 239000000725 suspension Substances 0.000 claims abstract description 27
- 238000000605 extraction Methods 0.000 claims abstract description 15
- 239000006071 cream Substances 0.000 claims abstract description 9
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 238000004108 freeze drying Methods 0.000 claims abstract description 9
- 238000007873 sieving Methods 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 8
- 238000010298 pulverizing process Methods 0.000 claims abstract description 3
- 239000000839 emulsion Substances 0.000 claims 1
- 238000009499 grossing Methods 0.000 claims 1
- 230000000050 nutritive effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 230000004089 microcirculation Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 230000001815 facial effect Effects 0.000 abstract description 8
- 239000006210 lotion Substances 0.000 abstract description 8
- 235000008935 nutritious Nutrition 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 206010040954 Skin wrinkling Diseases 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000005507 spraying Methods 0.000 abstract description 3
- 235000002673 Dioscorea communis Nutrition 0.000 abstract description 2
- 241000544230 Dioscorea communis Species 0.000 abstract description 2
- 208000035753 Periorbital contusion Diseases 0.000 abstract description 2
- 210000001508 eye Anatomy 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 18
- 239000003814 drug Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 8
- 238000005070 sampling Methods 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 5
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical group C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 5
- 244000046146 Pueraria lobata Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 210000000713 mesentery Anatomy 0.000 description 4
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001736 capillary Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229960003712 propranolol Drugs 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000000264 venule Anatomy 0.000 description 2
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000010837 Diabetic eye disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000270934 Rana catesbeiana Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229930012930 isoflavone derivative Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- -1 puerarin isoflavone derivatives Chemical class 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/044—Suspensions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Microbiology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a preparation method of kudzu root extract nanometer suspension for eye care, which comprises the following key steps: pulverizing dried radix Puerariae, sieving, adding deionized water, transferring to a pressure extractor, and extracting for a certain time under heat and pressure; after the extraction is finished, directly spraying the extracting solution into a beaker to obtain the pueraria extract nanometer suspension. The method for extracting the effective components of the kudzuvine root and preparing the nano suspension is completed in one step, and the preparation method is simple, convenient, green and safe. Compared with the radix Puerariae extract prepared by conventional extraction method, the radix Puerariae extract nanometer suspension has good transdermal absorption property and blood circulation promoting and blood stasis removing effects. The nanometer suspension can be directly added into eye care cosmetics such as cream, lotion, facial mask, various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying, and can fully exert the medicinal components of radix Puerariae for improving microcirculation, and prevent or relieve black eye, pouch, and crow's feet.
Description
The technical field is as follows:
the invention relates to a preparation method of a pueraria extract nanometer suspension and application of the pueraria extract nanometer suspension in eye care cosmetics, and belongs to the field of manufacturing and application of daily chemical raw materials.
Background art:
the eye is the most senescent and problematic site in the human body for the following reasons: firstly, the skin around the eyes is only 0.33-0.36 mm thick (corresponding to 1/3 on the face), and the eyes are the parts with the least distribution of sebaceous glands and sweat glands, so that the skin around the eyes is easy to dry and lack of water, and fine wrinkles are generated; secondly, the blinking frequency of each person reaches 2.4-2.8 thousands of times per day, and the eyes are easy to feel acerb and fatigue; thirdly, the capillary vessels around the eyes are very abundant in distribution, if the eyes are used excessively, poor circulation of the eyes and lymph is caused, and edema can occur due to poor circulation, so that blood can be accumulated in the eyes, and finally, the eyes are deeply disgorged, pain and eye bags are deeply died, dark circles are formed in the eyes, crow's feet and the like are generated. For the first two reasons causing eye aging, we are generally unable to do so, so improving microcirculation, re-waking the activity of fibrous connective tissue cells around the orbit, accelerating the metabolism of redundant fat and water in the eye, and relieving visual fatigue are the most important means for solving various problems of the eye.
Kudzu root is root of Pueraria lobata (willla) ohwi, which is a perennial bean plant, and isoflavone components represented by puerarin are main effective components in kudzu root. Modern pharmacological research considers that the drug effect components of the puerarin tablet have various effects of promoting blood circulation to remove blood stasis, improving microcirculation and the like, for example, the puerarin tablet or injection used clinically has good curative effect on treating diabetic eye diseases, and is widely researched and valued by the medical field. However, the puerarin isoflavone derivatives generally have the characteristics of short half-life period, P-gp efflux function, first-pass metabolic effect of intestinal enzymes and the like, have low oral bioavailability and need large-dose administration; in addition, the development of external transdermal absorption preparations is limited due to the characteristics of low water solubility and poor membrane permeability.
Nanosuspensions (nanosuspensions) are submicron colloidal dispersions of pure drug nanoparticles having a particle size of less than 1 μm, with a small amount of surfactant or other carrier as suspending agent. After the medicine is prepared into the nano suspension, the particle size of the medicine can be reduced, the specific surface area of the medicine can be increased, and the solubility of the insoluble medicine can be increased, so that the bioavailability of the medicine is improved.
The invention content is as follows:
the invention aims to provide a kudzuvine root extract nanosuspension which can prevent or relieve various problems of eyes by improving microcirculation of the eyes. The prepared suspension has high transdermal absorption rate, can effectively enhance the effect of the radix puerariae on improving microcirculation, and has no irritation to skin. Can be used as main ingredient for eye care cosmetic for preventing or relieving black eye, pouch, and crow's feet.
The purpose of the invention is realized by the following technical scheme:
(1) pulverizing dried radix Puerariae, sieving with 40 mesh sieve, and adding deionized water at a ratio of 1: 15-100;
(2) then transferring the mixture to a pressure extractor, pressurizing to 0.5MPa, controlling the temperature at 100 ℃ and 130 ℃, and keeping the temperature and the pressure for 10-60 min;
(3) after the extraction is completed, the extract is directly sprayed into a beaker through a sampling tube. Obtaining the kudzu root extract nanometer suspension.
(4) The obtained nanometer suspension can be directly added into cream, lotion, facial mask, and various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying.
Compared with the prior art, the invention has the beneficial effects that: extracting isoflavone components from radix Puerariae by subcritical water technology, and directly spraying radix Puerariae extractive solution into blank beaker. The extraction and the preparation of the nanoparticles are completed in one step, and the nanosuspension with the particle size within the range of 100-1000nm can be prepared by controlling the factors such as the extraction temperature, the time, the injection speed and the like. The nanometer suspension differs from the traditional nanometer particle in that the traditional nanometer particles such as nanometer liposome, lipid nanometer particle, polymer nanometer capsule, nanometer ball, polymer micelle and the like belong to matrix skeleton type, and are solid colloidal particles formed by wrapping the drug by high molecular polymer, and the nanometer suspension and the traditional nanometer particle have differences in concept and preparation process. In addition, the preparation process for preparing the nano suspension is different from the conventional nano suspension method, and because the kudzu root extract contains the components such as saponin, polysaccharide and the like, a surfactant, a suspending agent and the like are not required to be additionally added, so that the effect components are less influenced by an exogenous additive.
The invention has the main advantages that: the preparation process is simple and the cost is low; the kudzu root extract is added into the cosmetic matrix in a nanoparticle form, so that the skin permeation rate of the active ingredients is high, and the microcirculation improving effect is better.
Description of the drawings:
FIG. 1 is the in vitro transdermal cumulative release rate versus time curve for the nanosuspensions prepared in example 3 (1. extraction by conventional method, 2. subcritical water extraction);
FIG. 2 shows the results of the blood circulation-promoting and blood stasis-removing experiments of the nanosuspensions prepared in example 3 (1. propranolol group, 2. nanosuspension group, 3. water-decoction extract group, 4. physiological saline group).
The specific implementation mode is as follows:
the present invention will be described in further detail with reference to examples. It will be understood that these examples are intended to illustrate the invention and are not intended to limit the scope of the invention in any way. Terms used in the present invention have generally meanings as commonly understood by one of ordinary skill in the art, unless otherwise specified. Any method, process, product, etc. that complies with the principles and novel and inventive features disclosed herein and which complies with the claims or the description set forth herein falls within the scope of the present invention.
Example 1
(1) Crushing the dried kudzu root medicinal material, sieving the crushed kudzu root medicinal material by a 40-mesh sieve, and adding deionized water according to the proportion of 1: 50;
(2) then transferring to a pressurizing extractor, pressurizing to 0.5MPa, controlling the temperature at 120 ℃, and keeping the temperature and pressure for 10 min;
(3) after the extraction is completed, the extract is directly sprayed into a beaker through a sampling tube. Obtaining the kudzu root extract nanometer suspension.
(4) The obtained nanometer suspension can be directly added into cream, lotion, facial mask, and various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying.
Example 2
(1) Crushing the dried kudzu root medicinal material, sieving the crushed kudzu root medicinal material by a 40-mesh sieve, and adding deionized water according to the proportion of 1: 50;
(2) then transferring to a pressurizing extractor, pressurizing to 0.5MPa, controlling the temperature at 130 ℃, and keeping the temperature and pressure for 20 min;
(3) after the extraction is completed, the extract is directly sprayed into a beaker through a sampling tube. Obtaining the kudzu root extract nanometer suspension.
(4) The obtained nanometer suspension can be directly added into cream, lotion, facial mask, and various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying.
Example 3
(1) Crushing the dried kudzu root medicinal material, sieving the crushed kudzu root medicinal material by a 40-mesh sieve, and adding deionized water according to the proportion of 1: 50;
(2) then transferring to a pressurizing extractor, pressurizing to 0.5MPa, controlling the temperature at 120 ℃, and keeping the temperature and pressure for 20 min;
(3) after the extraction is completed, the extract is directly sprayed into a beaker through a sampling tube. Obtaining the kudzu root extract nanometer suspension.
(4) The obtained nanometer suspension can be directly added into cream, lotion, facial mask, and various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying.
Example 4
(1) Crushing the dried kudzu root medicinal material, sieving the crushed kudzu root medicinal material by a 40-mesh sieve, and adding deionized water according to the proportion of 1: 30;
(2) then transferring to a pressurizing extractor, pressurizing to 0.5MPa, controlling the temperature at 115 ℃, and preserving heat and pressure for 30 min;
(3) after the extraction is completed, the extract is directly sprayed into a beaker through a sampling tube. Obtaining the kudzu root extract nanometer suspension.
(4) The obtained nanometer suspension can be directly added into cream, lotion, facial mask, and various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying.
Example 5
(1) Crushing the dried kudzu root medicinal material, sieving the crushed kudzu root medicinal material by a 40-mesh sieve, and adding deionized water according to the proportion of 1: 30;
(2) then transferring to a pressurizing extractor, pressurizing to 0.2MPa, controlling the temperature at 125 ℃, and keeping the temperature and pressure for 40 min;
(3) after the extraction is completed, the extract is directly sprayed into a beaker through a sampling tube. Obtaining the kudzu root extract nanometer suspension.
(4) The obtained nanometer suspension can be directly added into cream, lotion, facial mask, and various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying.
Example 6
(1) Crushing the dried kudzu root medicinal material, sieving the crushed kudzu root medicinal material by a 40-mesh sieve, and adding deionized water according to the proportion of 1: 15;
(2) then transferring to a pressurizing extractor, pressurizing to 0.5MPa, controlling the temperature at 120 ℃, and keeping the temperature and pressure for 20 min;
(3) after the extraction is completed, the extract is directly sprayed into a beaker through a sampling tube. Obtaining the kudzu root extract nanometer suspension.
(4) The obtained nanometer suspension can be directly added into cream, lotion, facial mask, and various aqueous products (essence, nutritious water, and soothing water) or added after freeze drying.
Determination of total flavone content in kudzu vine root nano suspension
Measuring the content of flavonoid components in the extract by spectrophotometry. Dissolving puerarin as standard substance in 60% ethanol, diluting to constant volume, and measuring absorbance at 253 nm. The absorbance values were plotted against the concentration, and a standard curve a of 0.0142C +0.0706(R2 of 0.9981) was linearly regressed to calculate the pueraria flavonid content of examples 1-6 according to the standard curve, and the results are shown in table 1.
Particle size determination of kudzu root nano suspension
Examples 1-6 sample particle sizes were measured using a ZS90 malvern laser particle sizer. The results are shown in Table 1.
TABLE 1 EXAMPLES 1-6 AND WATER-DECOCATED EXTRACT FLUORINE SOLUTION FLAVONOID COMPONENT CONTENT AND PARTICULAR DISTRIBUTION
The extraction rate and the particle size distribution are comprehensively evaluated, and the kudzuvine root nano suspension is prepared under the process conditions of the example 3.
Skin allergy test (example 3)
According to a conventional method, 4 adult healthy rabbits are taken, the hair of the ear quilt with the area of 4cm multiplied by 4cm is removed by 8 percent sodium sulfide before the test, and the injury is determined after 24 hours of observation. The treated rabbits were randomly divided into 2 groups. The group 1 is an experimental group (smearing nanometer suspension), the group 2 is a blank group (giving distilled water), and then the skin allergy conditions of the rabbits are observed in 0h, 24h, 48h and 72h respectively.
The experimental result shows that after the drug is administrated, the ear skin of the rabbit has no change such as erythema, edema and the like, and the rabbit has no general allergic reaction such as asthma, unstable standing or shock and the like. The nanosuspension is shown to have no allergic reaction when being applied to the skin.
Acute toxicity test (example 3)
According to a conventional method, 4 adult healthy rabbits are taken, and the hair on two sides of the vertebral column of the rabbit, which is about 3cm multiplied by 3cm, is removed before administration. The treated rabbits were randomly divided into 2 groups, and the experimental group rubbed the skin with sterilized abrasive paper until the skin was damaged by bleeding; the control group was untreated and was intact skin. Two groups of rabbits were treated with the nanosuspensions separately. After 24h the drug was wiped off with warm water, observed, and then the spraying of the same drug was continued for 7 consecutive days. The animals were observed and recorded daily for changes in body weight, skin, hair, eyes and mucous membranes, respiration, limb movements and other toxic manifestations. The results show that the nano-suspension of the kudzu root extract has no irritation to normal intact skin and broken skin of rabbits within 24, 48 and 72 hours after multiple times of skin irritation.
Nanosuspension in vitro transdermal experiments (example 3)
With Na2S removing the abdominal hair of a healthy mouse, cleaning, cutting off the neck, killing, immediately cutting off the abdominal skin, removing subcutaneous adipose tissues and mucus tissues by a blade, cleaning by normal saline, and storing in a refrigerator for later use.
Nanosuspensions were prepared as in example 3. And taking the rat skin out of the refrigerator, recovering to room temperature, repeatedly washing the rat skin with normal saline, and lightly wiping the rat skin with filter paper. The skin was held between the delivery and receiving chambers using Franz diffusion cells (receiving cell volume 5.3mL, internal diameter 1cm, effective area 0.785cm2) with stratum corneum facing the delivery chamber. Precisely measuring appropriate amount of the nanosuspension, adsorbing the nanosuspension with filter paper (the area is slightly smaller than the area of the supply chamber), and making close contact with skin. 5ml of Phosphate Buffered Saline (PBS) (pH 7.4, L0mmol/L) is added into a receiving chamber, the temperature of a water bath is (32 +/-0.5) DEG C, the constant speed is 300r/min, 5ml of fresh medium is sampled at regular time in lh, 2h, 4h, 6h, 8h, 10h, 12h and 24h respectively and is immediately supplemented back, the filtration is carried out by a 0.45 mu m microporous membrane, and the concentration of the drug in the receiving solution is determined by an ultraviolet-visible spectrophotometry method. The in vitro permeability of the water decoction extract is determined by the same method. The experimental results are shown in figure 1.
Evaluation of the microcirculation improving effect of nanosuspension (example 3)
Taking one bullfrog, breaking the frog brain and spinal cord, fixing the frog on a frog board, cutting a cut at the ventral side, pulling out a section of small intestine, unfolding mesentery, and fixing the mesentery on the frog board by using a pin. Onto the surface of the container, the wilsonii solution is added dropwise to prevent drying. Observing the blood flow condition in arterioles, venules and capillaries under a 100-time microscope, and distinguishing the flow speed, direction and characteristics of the arterioles, venules and capillaries; dripping 0.01% adrenaline on the mesenteric blood vessel, and observing the change of the caliber of the blood vessel and the blood flow speed; after the change, the blood vessel is washed by the wilford liquid, and then the kudzuvine root nanometer suspension is dripped on the mesenteric blood vessel to observe the change of the caliber of the blood vessel and the blood flow speed. The results are shown in Table 2.
Table 2 nanosuspension improving microcirculation experiment results
After the radix puerariae nanometer suspension is added, the blood flow rate in mesentery circulation is accelerated, which shows that the blood circulation can relax blood vessels and promote the microcirculation of frog mesentery.
Evaluation of efficacy of nanosuspension for promoting blood circulation and removing blood stasis (example 3)
Mouse hypoxia tolerance test. 32 mice were divided into four groups, namely a blank control group (physiological saline), a positive control group (propranolol), an administration group 1 (nanosuspension), and an administration group 2 (water decoction extract). Taking adult mice with weight close to that of the adult mice, performing intragastric administration for 0.2ml/10g, respectively putting the adult mice into jars filled with soda lime after administration for 30min, and sealing the jars. The activity of the observed mice is compared, and the time of twitch appearance and survival time of the mice are recorded. The experimental results are shown in figure 2.
Through statistical analysis (t test), the p of the nano suspension group and the p of the normal saline group are less than 0.001, the difference is very obvious, the kudzu root nano suspension has the effect of prolonging the survival time of mice, the effect is close to that of propranolol serving as a positive control medicament, the p of a water decoction extract administration group and the p of the normal saline group is more than 0.1, and the effect of prolonging the survival time of the mice is not obvious.
Claims (2)
1. A preparation method of pueraria extract nanometer suspension is characterized by comprising the following process steps: pulverizing dried radix Puerariae, sieving, adding deionized water at a mass ratio of 1: 10-100, transferring into a pressure extractor under extraction pressure of 0.5MPa, at extraction temperature of 100-.
2. The pueraria lobata extract nanosuspension of claim 1, wherein the nanosuspension is added to a cream, an emulsion, a mask, a water product (a smoothing toner, a nutritive water, a soothing water) or the like for eye care directly or after freeze-drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111550426.0A CN114028298A (en) | 2021-12-16 | 2021-12-16 | Preparation method and application of pueraria extract nanosuspension for eye care |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111550426.0A CN114028298A (en) | 2021-12-16 | 2021-12-16 | Preparation method and application of pueraria extract nanosuspension for eye care |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114028298A true CN114028298A (en) | 2022-02-11 |
Family
ID=80140876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111550426.0A Pending CN114028298A (en) | 2021-12-16 | 2021-12-16 | Preparation method and application of pueraria extract nanosuspension for eye care |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028298A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101507698A (en) * | 2009-03-25 | 2009-08-19 | 天津郁美净集团有限公司 | Composite with whitening function and skin care product thereof and preparation method thereof |
CN105434284A (en) * | 2015-12-31 | 2016-03-30 | 天津达仁堂京万红药业有限公司 | Moisturizing and nourishing eye serum and preparation method thereof |
CN109498733A (en) * | 2019-01-07 | 2019-03-22 | 中国医学科学院药用植物研究所 | A kind of Resina Draconis nano suspension and preparation method thereof |
-
2021
- 2021-12-16 CN CN202111550426.0A patent/CN114028298A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101507698A (en) * | 2009-03-25 | 2009-08-19 | 天津郁美净集团有限公司 | Composite with whitening function and skin care product thereof and preparation method thereof |
CN105434284A (en) * | 2015-12-31 | 2016-03-30 | 天津达仁堂京万红药业有限公司 | Moisturizing and nourishing eye serum and preparation method thereof |
CN109498733A (en) * | 2019-01-07 | 2019-03-22 | 中国医学科学院药用植物研究所 | A kind of Resina Draconis nano suspension and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
周丽等: "亚临界水提取葛根中总异黄酮的研究", 中草药 * |
鲁传华;吴鸿飞;周安;闵智伟;张玉莲;: "葛根素纳米粒在小鼠体内的药动学", 中国医院药学杂志 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105963153B (en) | Active compound and cosmetics or skin care item comprising blue copper victory peptide | |
CN104825351B (en) | A kind of Lignum Aquilariae Resinatum whitening cleansing facial milk containing and preparation method thereof | |
ES2856480T3 (en) | Cosmetic uses of swertiamarin | |
CN110882201B (en) | Itching-relieving skin-care cream and preparation method thereof | |
KR20010000396A (en) | whiten toilet-ry | |
CN109044941B (en) | Skin firming, nourishing and moisturizing composition and preparation method and application thereof | |
CN105496917A (en) | Herba centellae anti-wrinkling face cream and preparation method thereof | |
CN106236687A (en) | A kind of crease-resistant facial cream of chlorophyll and preparation method thereof | |
CN113730272B (en) | Eye-protecting patch with eye fatigue relieving effect and preparation method thereof | |
KR101795709B1 (en) | Visage improvement patch and manufacturing method of same | |
CN105106068B (en) | Calm the nerves perfume | |
CN105686957A (en) | Electro-spinning nanofiber mask with core-shell structure and preparation method thereof | |
CN113133957A (en) | Plant fermentation lifting compact anti-oxidation anti-fatigue eye mask and preparation method thereof | |
CN109010220B (en) | Cosmetic composition and preparation method thereof | |
CN111905023A (en) | Cold and hot medicinal moxibustion with effects of relieving fatigue, reducing fine lines and protecting eyes and preparation method thereof | |
CN104398426A (en) | Mask for treating common acne | |
CN114028298A (en) | Preparation method and application of pueraria extract nanosuspension for eye care | |
CN114376964B (en) | Puerarin nanoparticle film-forming hydrogel preparation and preparation method thereof | |
KR20210040522A (en) | Cosmetic composition, cosmetic mask pack comprisint the same and preperation method of the cosmetic composition | |
CN115531276A (en) | Transdermal moisturizing essence and preparation method thereof | |
KR20160121268A (en) | Anti-aging composition comprising Cannabis satica extract | |
CN114587767A (en) | Cold compress cover, eye cold compress eye patch and preparation process thereof | |
WO2022142195A1 (en) | Microneedle patch and preparation method therefor | |
KR101436819B1 (en) | Cosmetic composition for moisturing, soothing skin and improving acne | |
CN114366707A (en) | Chinese herbal medicine active matter @ vesicle compound with hair nourishing and hair growing effects and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |